Pimea AI Overview
A steady increase in the prevalence of allergic diseases globally has occurred with about 30-40% of the world population now being affected by one or more allergic conditions. Modern healthcare bodies and authorities agree that they cannot cure an allergy, but can only treat the symptoms by either avoiding the allergen, taking medications (Antihistamines and Steroids, epinephrine (EpiPen)), or getting into a long-lasting treatment process of 2-4 years, called Immunotherapy. We are developing a digital personalized healthcare therapy that will revolutionize the global allergy industry and the a/m concept by offering a nonintrusive solution that leverages decades of impactful alternative medicine therapies and techniques to overcome allergies. Our solution utilizes advanced algorithms that analyze patients' physiological parameters to autonomously administer a proprietary therapeutic protocol that by accessing the subconscious mind retrains the immune system to avoid, or reduce, allergy inflammation for a long period, which means developing resilience to the disease and prevent allergy symptoms for an extended period. Our methodology is firmly rooted in the modern holistic healthcare paradigm, which seamlessly integrates conventional medicine with complementary and alternative practices. The treatment, a quick 20- to 30-minute session, can be seamlessly integrated into mainstream healthcare or employed as a standalone therapy. Drawing inspiration from the scientific field of psychoneuroimmunology, our treatments address each patient's mental state and mindset. Pimea AI is committed to ushering in a new era of allergy relief that prioritizes individual well-being and long-term health.
Latest News
No news articles.
| Sector | Health Tech & Life Sciences |
Funding
| Total funding | Undisclosed |
| Last funding | Undisclosed |
| Stage | Pre-Funding |
| Rounds | 0 |
| Investors | 0 |
Team Members
1
Employees: 1-10
Web & Social Links
| Website | pimea-ai.com/ |
Locations
Tel Aviv-Yafo, Israel
Photos & Videos
No files yet
Pimea AI Business
Sector
Health Tech & Life SciencesDigital HealthcareDigital TherapeuticsMedical DevicesMedical Treatment & TherapeuticsTarget Customer
ConsumersHealthcare & Life SciencesHealthcareProvidersPatientsCore Technology
SensingPlatforms & InterfacesSoftwareArtificial IntelligenceTags (18)
healthcare-providersalgorithmspersonalized-treatmentchronic-patientsautoimmune-diseasesimmunologydigital-therapeuticsdigital-healthcaresoftware-applicationsallergynon-invasivetreatmentsartificial-intelligencedata-analyticsneurologyclinicspharma-companiesmachine-learningGeographic Markets
GlobalNorth AmericaPimea AI Financials
Pimea AI Lifecycle
Pimea AI News
0 articlesNo news articles.
Pimea AI Team
Employee Info
| Employees (range) | 1-10 |
| Exact count | 3 |
| Team members | 1 |
Similar Companies
Similar companies data is computed dynamically and not stored in the entity profile. This section requires implementing a similarity query (e.g. by classification overlap, sector, district).
This entity has 14 classification IDs that could be used for matching.
Pimea AI Internal
Recent Updates
No update log entries.
Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.
Admin Info
| Confidence | 95/100 |
| Missing | video or image, funding rounds, news, markets, external profiles |
| BI Verification | Yotam Maman |
| Phone | +972-54-2688577 |
| Creator | Omer Hevlin |
| Creator email | omer@silverline-ia.com |
| Last updater | Matan Eblagon |
| Updater email | matane@sncentral.org |
| Last update | 2023-04-10T00:00:00.000Z |
| Created | 2021-05-30T00:00:00.000Z |
| Claimed | Yes |